OBJECT: This study has two objectives: (1) to compare the kinetics of low diffusion P846 with Gd-DOTA using inversion recovery echo planar (IR-EPI) magnetic resonance (MR) imaging and (2) to determine the potential of P846 in defining myocardial viability in hearts subjected to various injuries using T1-weighted spin echo (T1-SE). MATERIALS AND METHODS: Rats were subjected to (1) occlusive infarcts (n = 16), (2) reperfused ischemic injuries (n = 8) or (3) reperfused infarcts (n = 16). A dose of 0.05 mmol/kg P846 was compared to 0.1 mmol/kg Gd-DOTA. IR-EPI and T1-SE images were obtained during 60 min. T(1), DeltaR(1) and DeltaR(1) ratio were measured on IR-EPI. Infarct extents were evaluated on T1-SE and compared with histochemical staining. RESULTS: Blood DeltaR(1) was higher at 5 min after P846 (6.36 +/- 0.32 s(-1)) than after Gd-DOTA (1.30 +/- 0.14 s(-1); P < 0.001). With P846, occlusive infarcts appeared as a hypoenhanced region surrounded by a hyperenhanced rim that lasted for 60 min. The increase in the DeltaR(1) ratio value was slower after P846 than with Gd-DOTA in the reperfused infarcts, suggesting low diffusion/convection of P846. Gd-DOTA homogenously enhanced both occlusive and reperfused infarcts at 30 min. CONCLUSION: P846 provides better contrast and extended discrimination between occlusive and reperfused infarcts compared with Gd-DOTA. The gadolinium dose could be reduced with P846.
OBJECT: This study has two objectives: (1) to compare the kinetics of low diffusion P846 with Gd-DOTA using inversion recovery echo planar (IR-EPI) magnetic resonance (MR) imaging and (2) to determine the potential of P846 in defining myocardial viability in hearts subjected to various injuries using T1-weighted spin echo (T1-SE). MATERIALS AND METHODS:Rats were subjected to (1) occlusive infarcts (n = 16), (2) reperfused ischemic injuries (n = 8) or (3) reperfused infarcts (n = 16). A dose of 0.05 mmol/kg P846 was compared to 0.1 mmol/kg Gd-DOTA. IR-EPI and T1-SE images were obtained during 60 min. T(1), DeltaR(1) and DeltaR(1) ratio were measured on IR-EPI. Infarct extents were evaluated on T1-SE and compared with histochemical staining. RESULTS: Blood DeltaR(1) was higher at 5 min after P846 (6.36 +/- 0.32 s(-1)) than after Gd-DOTA (1.30 +/- 0.14 s(-1); P < 0.001). With P846, occlusive infarcts appeared as a hypoenhanced region surrounded by a hyperenhanced rim that lasted for 60 min. The increase in the DeltaR(1) ratio value was slower after P846 than with Gd-DOTA in the reperfused infarcts, suggesting low diffusion/convection of P846. Gd-DOTA homogenously enhanced both occlusive and reperfused infarcts at 30 min. CONCLUSION: P846 provides better contrast and extended discrimination between occlusive and reperfused infarcts compared with Gd-DOTA. The gadolinium dose could be reduced with P846.
Authors: Maythem Saeed; Oliver Weber; Randall Lee; Loi Do; Alastair Martin; David Saloner; Philip Ursell; Philippe Robert; Claire Corot; Charles B Higgins Journal: J Am Coll Cardiol Date: 2006-10-31 Impact factor: 24.094
Authors: Christoph U Herborn; Elmar Honold; Michael Wolf; Jörn Kemper; Sonja Kinner; Gerhard Adam; Jörg Barkhausen Journal: Invest Radiol Date: 2007-01 Impact factor: 6.016
Authors: M F Wendland; M Saeed; K K Yu; T P Roberts; K Lauerma; N Derugin; J Varadarajan; A D Watson; C B Higgins Journal: Magn Reson Med Date: 1994-09 Impact factor: 4.668
Authors: O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd Journal: Radiology Date: 2001-01 Impact factor: 11.105
Authors: R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: D L Kraitchman; H B Hillenbrand; I Oznur; J A Lima; E R McVeigh; E A Zerhouni; D A Bluemke Journal: J Cardiovasc Magn Reson Date: 2000 Impact factor: 5.364
Authors: Padma Kaul; Paul W Armstrong; Wei-Ching Chang; C David Naylor; Christopher B Granger; Kerry L Lee; Eric D Peterson; Robert M Califf; Eric J Topol; Daniel B Mark Journal: Circulation Date: 2004-09-20 Impact factor: 29.690
Authors: Peter Marckmann; Lone Skov; Kristian Rossen; James Goya Heaf; Henrik S Thomsen Journal: Nephrol Dial Transplant Date: 2007-05-04 Impact factor: 5.992
Authors: M F Wendland; M Saeed; K Lauerma; N Derugin; J Mintorovitch; F M Cavagna; C B Higgins Journal: Magn Reson Med Date: 1997-03 Impact factor: 4.668
Authors: Louke J Delrue; Veerle Casneuf; Nancy Van Damme; Peter Blanckaert; Marc Peeters; Wim P Ceelen; Philippe C O Duyck Journal: MAGMA Date: 2011-05-13 Impact factor: 2.310